Fortrea Holdings (FTRE) EBT Margin (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly EBT Margin came in at 0.18% in Q2 2026, up 5201.0% YoY from 0.0% in Q2 2025, and up 90.84% on a QoQ basis from 1.93% in Q1 2026.
Fortrea Holdings (FTRE) EBT Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of EBT Margin data on file, last reported at 0.18% in Q2 2026.
- Quarterly EBT Margin rose 5201.0% year-over-year to 0.18% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 2.91% (up 3475.0% YoY) and the FY2025 annual result came in at 36.09%, down 2590.0% from the prior year.
- EBT Margin advanced to 0.18% in Q2 2026, from 1.93% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 10.54% in Q2 2022 to a low of 84.14% in Q1 2025.
- A 5-year average of 10.27% and a median of 4.09% in 2025 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2025 — EBT Margin slumped 7271 bps — and 2026, when it surged 8221 bps.
- Tracing FTRE's EBT Margin over 5 years: stood at 1.65% in 2022, then sank by 367 bps to 7.71% in 2023, then plunged by 39 bps to 10.75% in 2024, then jumped by 50 bps to 5.39% in 2025, then jumped by 97 bps to 0.18% in 2026.
- The last three EBT Margin figures came in at 0.18% (Q2 2026), 1.93% (Q1 2026), and 5.39% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | -0.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18% |
| Mar 31, 2026 | -1.93% |
| Dec 31, 2025 | -5.39% |
| Sep 30, 2025 | -4.09% |
| Jun 30, 2025 | -52.19% |
| Mar 31, 2025 | -84.14% |
| Dec 31, 2024 | -10.75% |
| Sep 30, 2024 | -5.30% |
| Jun 30, 2024 | -13.38% |
| Mar 31, 2024 | -11.43% |
| Dec 31, 2023 | -7.71% |
| Sep 30, 2023 | -3.07% |
| Jun 30, 2023 | 5.05% |
| Mar 31, 2023 | 1.37% |
| Dec 31, 2022 | -1.65% |
| Sep 30, 2022 | 9.73% |
| Jun 30, 2022 | 10.54% |